As Korea remains an area of intermediate HBV prevalence, and that the burden of liver cancer is especially great among individuals with low socioeconomic status [32], efforts to increase the liver cancer screening rate, following recommended methods (both abdominal ultrasonography and serum AFP testing) and intervals (6 months) for those at high risk are necessary. The gene discussed is AFP; the disease is liver cancer.